未登录

J

Jaffer Alsolaiss

Liverpool School of Tropical Medicine

H指数:12

被引数:652

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Investigating Snake-Venom-Induced Dermonecrosis and Inflammation Using an Ex Vivo Human Skin Model

IF4

2024-06-171

OAAI

Commercial Antivenoms Exert Broad Paraspecific Immunological Binding and In Vitro Inhibition of Medically Important Bothrops Pit Viper Venoms

商业抗蛇毒血清具有广泛的副特异性免疫结合作用，并在体外抑制医学上重要的botrops vit毒液

IF4

2022-12-208

OAAI

Two snakebite antivenoms have potential to reduce Eswatini's dependency upon a single, increasingly unavailable product: Results of preclinical efficacy testing

PLOS NEGLECTED TROPICAL DISEASES

IF3.4

2022-09-159

OAAI

Exploring the Utility of ssDNA Aptamers Directed against Snake Venom Toxins as New Therapeutics for Snakebite Envenoming

IF4

2022-07-0814

OAAI

Virus-like particles displaying conserved toxin epitopes stimulate polyspecific, murine antibody responses capable of snake venom recognition

SCIENTIFIC REPORTS

IF3.9

2022-07-056

OAAI

Exploring the Utility of Recombinant Snake Venom Serine Protease Toxins as Immunogens for Generating Experimental Snakebite Antivenoms

探索重组蛇毒丝氨酸蛋白酶毒素作为免疫原产生实验性蛇咬伤抗蛇毒的效用

IF4

2022-06-2916

OAAI

Pathology-specific experimental antivenoms for haemotoxic snakebite: The impact of immunogen diversity on the in vitro cross-reactivity and in vivo neutralisation of geographically diverse snake venoms (vol 15, e0009659, 2021)

PLOS NEGLECTED TROPICAL DISEASES

IF3.4

2022-06-020

OAAI

In vitro and in vivo preclinical venom inhibition assays identify metalloproteinase inhibiting drugs as potential future treatments for snakebite envenoming by Dispholidus typus

IF2.8

2022-06-0120

OAAI

Profiling the Murine Acute Phase and Inflammatory Responses to African Snake Venom: An Approach to Inform Acute Snakebite Pathology

IF4

2022-03-226

OAAI

Pathology-specific experimental antivenoms for haemotoxic snakebite: The impact of immunogen diversity on the in vitro cross-reactivity and in vivo neutralisation of geographically diverse snake venoms

PLOS NEGLECTED TROPICAL DISEASES

IF3.4

2021-08-1812

OAAI

A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite (vol 11, 6094, 2020)

NATURE COMMUNICATIONS

IF15.7

2021-06-240

OAAI

A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite

NATURE COMMUNICATIONS

IF15.7

2020-12-1587

OAAI

In Vitro Immunological Cross-Reactivity of Thai Polyvalent and Monovalent Antivenoms with Asian Viper Venoms

IF4

2020-12-0313

OAAI

Preclinical antivenom-efficacy testing reveals potentially disturbing deficiencies of snakebite treatment capability in East Africa (vol 11, e0005969, 2017)

PLOS NEGLECTED TROPICAL DISEASES

IF3.4

2020-08-311

OAAI

Preclinical validation of a repurposed metal chelator as an early-intervention therapeutic for hemotoxic snakebite

重新使用的金属螯合剂作为血液毒性蛇咬伤的早期干预疗法的临床前验证

SCIENCE TRANSLATIONAL MEDICINE

IF14.6

2020-05-0661

OAAI

Evaluation of the geographical utility of Eastern Russell's viper (Daboia siamensis) antivenom from Thailand and an assessment of its protective effects against venom-induced nephrotoxicity

PLOS NEGLECTED TROPICAL DISEASES

IF3.4

2019-10-2327

OAAI

Preclinical antivenom-efficacy testing reveals potentially disturbing deficiencies of snakebite treatment capability in East Africa

PLOS NEGLECTED TROPICAL DISEASES

IF3.4

2017-10-1883

OAAI